A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group. - Wolffenbuttel,B.H.; Landgraf,R. (Diabetes Care, 1999)